Business Context and Reporting Period
Company: MEDICINOVA INC
Filing Type: Form 8-K (Current Report)
Date of Report: February 25, 2009
Event: Entry into a Material Definitive Agreement and Creation of a Direct Financial Obligation.
Key Financial Metrics
- Credit Facility Type: Uncommitted, demand revolving line of credit secured by auction rate securities.
- Lender: UBS Bank USA.
- Collateral: Auction rate securities pledged by MediciNova.
- Previous Availability: $15,900,000 (implied by increase).
- Increased Availability: $2,200,000.
- Total Availability Post-Increase: $18,100,000.
- Amount Borrowed: $2,200,000 (drawn immediately upon increase).
- Total Outstanding Debt: $18,100,000.
Material Changes
On February 25, 2009, UBS Bank USA increased MediciNova's availability under an existing Credit Line Agreement by $2,200,000. The company immediately borrowed the full amount of the increase, raising the total outstanding balance under the facility to $18,100,000. This action represents a direct financial obligation created on the reporting date.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on future operations, or specific risk factors beyond the nature of the credit agreement. The credit line is uncommitted and demand-based, with availability determined by the lender's sole discretion regarding the market value of pledged auction rate securities.
Investor Verification Checklist
- Verify the current market value of the pledged auction rate securities to assess collateral adequacy.
- Confirm the interest rate and repayment terms of the uncommitted demand line.
- Review the company's liquidity position to determine reliance on this facility for operations.
- Check for any subsequent filings regarding the status of the pledged securities or the credit line.